Foundation Medicine Inc Stock

Stocks

18-10-21	Bayer : Roche takes on Loxo, Bayer in gene-defined cancer class	RE
18-06-19	Citigroup : Roche pays $2.4 billion for rest of cancer expert Foundation Medicine	RE
17-12-04	Foundation Medicine : Roche's Foundation Medicine wins FDA blessing for new cancer test	RE
15-01-12	Alcoa : Wall St. falls; energy shares dragged down further by oil	RE
15-01-12	Foundation Medicine : Roche in $1 billion-plus Foundation Medicine deal to boost cancer efforts	RE

18-08-07	Foundation Medicine : Setting the Pace for Blood Tumor Mutational Burden	PU
18-08-06	Foundation Medicine : Publishes New Data in Nature Medicine Supporting Blood Tumor Mutational Burden (bTMB) as a Novel Predictor of Response to Cancer Immunotherapy	BU
18-07-18	Foundation Medicine : and Guardant Health Agree to Settle Patent Infringement Lawsuit	BU
18-07-03	Beyond MSI: Expanding the Reach of Immunotherapy in Colorectal Cancer	PU
18-06-20	FOUNDATION MEDICINE, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU

18-06-19	Les valeurs à suivre aujourd'hui à Wall Street Mardi 19 juin 2018
18-06-19	Dow Jones Industrial Average : Les valeurs à suivre à Wall Street
18-06-19	FOUNDATION MEDICINE : racheté par ROCHE
18-06-19	USA-Les valeurs à suivre à Wall Street (actualisé)
18-06-19	Foundation Medicine : Roche will US-Gentest-Firma FMI ganz schlucken

Manager	Title	Age	Since
Daniel Andrzej Malarek CEO	Chief Executive Officer	-	2023-10-31
Dominique Schutz DFI	Director of Finance/CFO	-	2021-12-31
Michael Kling CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Evan Jones BRD	Director/Board Member	69	2013-01-07

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FOUNDATION MEDICINE INC	-.--%	-.--%	-	-	0
LONZA GROUP AG	+0.58%	+2.06%	+3.90%	+10.40%	50.73B
REVOLUTION MEDICINES, INC.	-2.22%	-1.25%	+391.53%	+591.38%	39.73B
IQVIA HOLDINGS INC.	-0.54%	+0.39%	+27.67%	-3.89%	34.69B
BEONE MEDICINES AG	-1.36%	+0.35%	+19.34%	+58.83%	33.21B
CELLTRION, INC.	+1.21%	-4.58%	+3.00%	+37.03%	26.76B
ASCENDIS PHARMA A/S	-1.81%	-1.48%	-	-	16.8B
MEDPACE HOLDINGS, INC.	+0.51%	-3.47%	+66.38%	+125.61%	15.37B
EUROFINS SCIENTIFIC SE	+0.23%	-0.58%	+13.80%	+19.56%	13.78B
ICON PUBLIC LIMITED COMPANY	-0.62%	-3.09%	+11.43%	-29.93%	12.85B
Average	-0.40%	-0.83%	+67.13%	+101.12%	27.1B
Weighted average by Cap.	-0.48%	-0.23%	+82.75%	+126.14%